GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-MER Medical Holdings Ltd (HKSE:03309) » Definitions » Cash Flow from Financing

C-MER Medical Holdings (HKSE:03309) Cash Flow from Financing : HK$-244 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is C-MER Medical Holdings Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Jun. 2024, C-MER Medical Holdings paid HK$33 Mil more to buy back shares than it received from issuing new shares. It spent HK$1 Mil paying down its debt. It paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0 Mil from paying cash dividends to shareholders. It spent HK$9 Mil on other financial activities. In all, C-MER Medical Holdings spent HK$42 Mil on financial activities for the six months ended in Jun. 2024.


C-MER Medical Holdings Cash Flow from Financing Historical Data

The historical data trend for C-MER Medical Holdings's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-MER Medical Holdings Cash Flow from Financing Chart

C-MER Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -66.61 312.02 85.12 293.68 -242.88

C-MER Medical Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 240.36 53.32 -102.27 -140.61 -103.70

C-MER Medical Holdings Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

C-MER Medical Holdings's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

C-MER Medical Holdings's Cash from Financing for the quarter that ended in Jun. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-244 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-MER Medical Holdings  (HKSE:03309) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

C-MER Medical Holdings's issuance of stock for the six months ended in Jun. 2024 was HK$0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

C-MER Medical Holdings's repurchase of stock for the six months ended in Jun. 2024 was HK$-33 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

C-MER Medical Holdings's net issuance of debt for the six months ended in Jun. 2024 was HK$-1 Mil. C-MER Medical Holdings spent HK$1 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

C-MER Medical Holdings's net issuance of preferred for the six months ended in Jun. 2024 was HK$0 Mil. C-MER Medical Holdings paid HK$0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

C-MER Medical Holdings's cash flow for dividends for the six months ended in Jun. 2024 was HK$0 Mil. C-MER Medical Holdings received HK$0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

C-MER Medical Holdings's other financing for the six months ended in Jun. 2024 was HK$-9 Mil. C-MER Medical Holdings spent HK$9 Mil on other financial activities.


C-MER Medical Holdings Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of C-MER Medical Holdings's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


C-MER Medical Holdings Business Description

Traded in Other Exchanges
N/A
Address
1-3 Pedder Street, Room 1535, China Construction Building, Central, Hong Kong, HKG
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The Group currently has 70 medical institutions in Hong Kong and the Mainland, including more than 40 specialists and other medical facilities in Hong Kong.
Executives
C-mer Group Limited 2101 Beneficial owner
Lam Shun Chiu Dennis 2201 Interest of corporation controlled by you
Li Xiaoting 2201 Interest of corporation controlled by you

C-MER Medical Holdings Headlines

No Headlines